Thank you for claiming your business. Kindly check your Email for verification mail from Sulekha.com Our team will contact you shortly!.
About Fabrus
Fabrus has developed a new "operating system" for antibody discovery: spatially addressed libraries. We are the only company that does NOT use some form of immunization or display (e.g. phage, yeast, etc.). As such, our cutting-edge platform has major advantages including speed, ability to multiplex targets, rapid identification of well-expressed leads, and ease of discovery directly on the cell surface. We have the ability to address membrane targets that cannot easily be purified (like GPCRs), and identify novel mechanisms of action. These areas are not amenable to other technologies and are enormously important in the pharmaceutical industry. Specialties Antibody Discovery, Biologics Development, Protein Engineering, Immunotherapy